Their subject was the new technology of recombinant DNA — molecules created in a laboratory by stitching together genetic material from different organisms. Researchers were excited by the ...

Developments include cell-based and recombinant DNA technologies. The global influenza vaccine market is projected to cross $14b by 2032, according to DelveInsight. The sector’s expansion is ...

The Global Recombinant DNA Technology Market was valued at approximately USD $$ billion in 2022 and is expected to grow at a healthy CAGR of over $% from 2023 to 2030. Recombinant DNA Technology ...

It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for clients across the globe - EffiX™ delivers ...

It serves as a comprehensive solution for the development and manufacturing of non-monoclonal antibody (non-mAb) recombinant proteins and plasmid DNA for ... launching of new technology platforms ...

EffiXTM is designed to meet the industry's demand for a high-yield, stable, and non-lysogenic E. coli expression system. It serves as a ...

Genetic technologies have the potential to help solve the ever-growing challenges of food insecurity and global health. But for this potential to be met, regulations that hinder scientific innovation ...

When researchers discover a new technology, its potential isn't always obvious. No one knew at first that email would become ...

The major national regulatory regimes for agbiotech products fail to satisfy scientific legitimacy on several counts. Every nation claims its agbiotech regulatory policies governing genetically ...